Background and Purpose— Atherosclerosis is a diffuse, chronic inflammatory disorder that
involves the vascular, metabolic, and immune systems and leads to plaque vulnerability. The …

Background Patients who have had a stroke with unknown time of onset have been previously
excluded from thrombolysis. We aimed to establish whether intravenous alteplase is safe …

Intracerebral haemorrhage (ICH) still represents the most feared complication of thrombolysis.
Our aim was to review the literature regarding clinical, biological and imaging predictors …

Despite the involvement of cerebellar ataxia in a large variety of conditions and its frequent
association with other neurological symptoms, the quantification of the specific core of the …

Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Background and Purpose— T2*-weighted gradient-echo MRI is known to detect old microbleeds
(MBs), considered indicative of microangiopathy. MBs might be a potential risk factor for …

Background The use of intensive lipid-lowering therapy by means of statin medications is
recommended after transient ischemic attack (TIA) and ischemic stroke of atherosclerotic origin…

… Black line: ERP grand average for normal controls (N = 5); Colored lines: ERPs for each
parietal patient. (N= 4). Signal was averaged over beep-locked epochs (from -200 ms to +1000 …

Background and Purpose— Intravenous tissue plasminogen activator improves outcome after
ischemic stroke when given within 3 hours of symptoms onset in carefully selected patients…

Background— Susceptibility-weighted (SW) MRI provides insight into the pathophysiology of
acute stroke. We report on the use of SW imaging (SWI) sequences in clinical practice and …